Gastrointestinal Stromal Tumors × Head & Neck × 30 days × Clear all
NCT02834013 2026-06-03

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

National Cancer Institute (NCI)

Phase 2 Active not recruiting
798 enrolled
NCT07124000 2026-06-01

DP-04

AstraZeneca

Recruiting
100 enrolled